ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Gene
Volume 128, Issue 1, 15 June 1993, Pages 37-42
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (699 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
Special issue
View Record in Scopus
 
doi:10.1016/0378-1119(93)90150-2    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 1993 Published by Elsevier B.V.

A ribonuclease S-peptide antagonist discovered with a bacteriophage display library

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

George P. SmithCorresponding Author Contact Information, a, David A. Schultzb and John E. Ladburyb, c

aDivision of Biological Sciences, University of Missouri, Columbia, MO 65211, USA

bDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA. Tel. (203)432-5794

cDepartment of Chemistry, Yale University, New Haven, CT 06511, USA. Tel. (203)432-5206


Received 11 February 1993. 
Available online 16 January 2003.

Abstract

From a filamentous phage library displaying random hexapeptides, we selected clones displaying peptides that bind S-protein, a 104-amino-acid (aa) fragment of bovine pancreatic ribonuclease (RNase). The selected peptides show a sequence motif, (F/Y)NF(E/V)(I/V)(L/V), that bears little resemblance to S-peptide, a 20-aa fragment of RNase that is S-protein's natural ligand. One of the displayed peptides, YNFEVL, was synthesized chemically and shown by isothermal titration calorimetry to bind S-protein with a dissociation equilibrium constant of 5.5 βM at 25°C, an affinity comparable to that of previously studied S-peptide variants. The YNFEVL peptide is an antagonist of S-peptide, in that it blocks the ability of S-peptide to restore enzyme activity to S-protein. The S-protein/S-peptide system preserves the essential features of a pharmacologically significant receptor/hormone couple, and the S-peptide antagonist can therefore be regarded as a new RNase-specific ‘drug’. This work illustrates the potential value of phage display libraries for discovering novel classes of pharmaceuticals.

Keywords: Drug discovery; random hexapeptide library; filamentous bacteriophage; peptide epitope; hormone receptor; titration calorimetry

Abbreviations: A, absorbance (1 cm); aa, amino acid(s); BSA, bovine serum albumin; cpm, counts per min; ΔHb, enthalpy of binding interaction; Kd, dissociation equilibrium constant; pill, coat protein encoded by filamentous phage gene III; RNase, bovine pancreatic ribonuclease; S-peptide and S-protein, fragments produced by limited cleavage of RNase with subtilisin; S15, first 15 aa of S-peptide; TBS, 0.15 M NaCl/50mM Tris·HCl pH 7.5; TBS/Tween, TBS with 0.5% (v/v) Tween-20


Corresponding Author Contact InformationCorrespondence to: Dr. G.P. Smith, Tucker Hall, University of Missouri, Columbia, MO 65211, USA. Tel. (314)882-3344; Fax (314)882-0123.

Gene
Volume 128, Issue 1, 15 June 1993, Pages 37-42
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.